Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1197-1202

  Song, Ik Chan ^a   Liang, Zhe Long ^a   Lee, Jung Chan ^a   Huang, Song Mei ^a   Kim, Ha Yon ^a   Oh, Yoon Suk ^a   Yun, Hwan Jung ^a   Sul, Ji Young ^a   Jo, Deog Yeon ^a   Kim, Samyong ^a   Kim, Jin Man ^a   Lee, Hyo Jin ^a  

^a Chungnam National University   (South Korea)

Author keywords

Early gastric cancer; Lymph node metastasis; SDF 1

Indexed keywords

STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; CORRELATION COEFFICIENT; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDEPENDENT VARIABLE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALIDITY; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; STATISTICAL SIGNIFICANCE; STOMACH CANCER; UNIVARIATE ANALYSIS;

EID: 80052754217     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.389     Document Type: Article

References (36)

1. Okamura T, Tsujitani S, Korenaga D, Haraguchi M, Baba H, Hiramoto Y and Sugimachi K: Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg 155: 476-480, 1988.
2. Park YD, Chung YJ, Chung HY, et al: Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy 40: 7-10, 2008.
3. Isozaki H, Tanaka N and Okajima K: General and specific prognostic factors of early gastric carcinoma treated with curative surgery. Hepatogastroenterology 46: 1800-1808, 1999.
4. Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D and Sugimachi K: Predictors of lymph node metastasis in early gastric cancer. Br J Surg 79: 245-247, 1992.
5. Folli S, Dente M, Dell'Amore D, Gaudio M, Nanni O, Saragoni L and Vio A: Early gastric cancer: prognostic factors in 223 patients. Br J Surg 82: 952-956, 1995.
6. Kitamura K, Yamaguchi T, Taniguchi H, Hagiwara A, Sawai K and Takahashi T: Analysis of lymph node metastasis in early gastric cancer: rationale of limited surgery. J Surg Oncol 64: 42-47, 1997.
7. Habu H, Takeshita K, Sunagawa M and Endo M: Lymph node metastasis in early gastric cancer. Int Surg 71: 244-247, 1986.
8. Folli S, Morgagni P, Roviello F, et al: Italian Research Group for Gastric Cancer (IRGGC), Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 31: 495-499, 2001.
9. Kwee RM and Kwee TC: Predicting lymph node status in early gastric cancer. Gastric Cancer 11: 134-148, 2008.
10. Brennan MF: Current status of surgery for gastric cancer: a review. Gastric Cancer 8: 64-70, 2005.
11. Nakajima T: Gastric cancer treatment guidelines in Japan. Gastric Cancer 5: 1-5, 2002.
12. Krop IE: Chemokine signaling in gliomas: prognostic factor, therapeutic target or both? Cancer Biol Ther 5: 1039-1041, 2006.
13. Burger JA and Kipps TJ: CXCR 4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767, 2006.
14. Arya M, Patel HR and Williamson M: Chemokines: key players in cancer. Curr Med Res Opin 19: 557-564, 2003.
15. Scotton CJ, Wilson JL, Scott K, et al: Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62: 5930-5938, 2002.
16. Koshiba T, Hosotani R, Miyamoto Y, et al: Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6: 3530-3535, 2000.
17. Ishigami S, Natsugoe S, Okumura H, et al: Clinical implication of CXCL12 expression in gastric cancer. Ann Surg Oncol 14: 3154-3158, 2007.
18. Iwasa S, Yanagawa T, Fan J and Katoh R: Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res 29: 4751-4758, 2009.
19. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1: 10-24, 1998.
20. Li C, Kim S, Lai JF, et al: Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol 15: 1464-1469, 2008.
21. Kanai T, Konno H, Maruyama K, et al: p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer. Eur Surg Res 29: 35-41, 1997.
22. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T and Sugimachi K: Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 6: 3581-3584, 2000.
23. Yonemura Y, Ninomiya I, Ohoyama S, et al: Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer. Oncology 49: 363-367, 1992.
24. Salmaggi A, Gelati M, Pollo B, et al: CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol 74: 287-293, 2005.
25. Calatozzolo C, Maderna E, Pollo B, et al: Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther 5: 827-832, 2006.
26. Sasaki K, Natsugoe S, Ishigami S, et al: Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer. J Surg Oncol 97: 397-402, 2008.
27. Sasaki K, Natsugoe S, Ishigami S, et al: Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Oncol Rep 21: 65-71, 2009.
28. Wagner PL, Hyjek E, Vazquez MF, et al: CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 137: 615-621, 2009.
29. Yoshitake N, Fukui H, Yamagishi H, et al: Expression of SDF-1 α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98: 1682-1689, 2008.
30. Barbieri F, Bajetto A, Stumm R, et al: Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 14: 5022-5032, 2008.
31. Rempel SA, Dudas S, Ge S and Gutiérrez JA: Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6: 102-111, 2000.
32. Bajetto A, Barbieri F, Dorcaratto A, et al: Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 49: 423-432, 2006.
33. Barbero S, Bonavia R, Bajetto A, et al: Stromal cell-derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63: 1969-1974, 2003.
34. Li M and Ransohoff RM: The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin Cancer Biol 19: 111-115, 2009.
35. Guleng B, Tateishi K, Ohta M, et al: Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65: 5864-5871, 2005.
36. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005.